GSK Shares Dip Post-Acquisition, Asia Markets Rally, Indonesia Fiscal Policy Focus

1. GSK's $10.6 billion acquisition of Nuvalent resulted in a 3% share drop in early trading, despite the CEO's defense of the strategic deal.
2. South Korean (KOSPI) and Japanese (Nikkei 225) stock markets surged by 8.18% and 2.17% respectively, driven by strong gains in tech giants like SK Hynix and Samsung Electronics.
3. Indonesia's Finance Minister projected a 2026 GDP growth of 5.4%-6% and emphasized strengthening fiscal and monetary policy coordination amidst global uncertainty.